Electromyostimulation (EMS) of Astronauts in Spaceflight (Easymotion-2)
Launched by CHARITE UNIVERSITY, BERLIN, GERMANY · Jul 1, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The Easymotion-2 trial is a study designed to explore how a special suit, called the EasyMotionSkin, can help astronauts maintain their muscle strength and prevent muscle problems while they are in space. This suit uses electric stimulation to activate muscles, which may provide a helpful alternative to traditional exercise in the unique environment of space. The goal is to see if this method can improve exercise results for astronauts on long missions, making it easier for them to stay fit and healthy for future space explorations.
To participate in this study, astronauts must meet certain health criteria. They need to be medically cleared for flight and should not have serious health issues like heart disease, diabetes, or cancer. During the study, each astronaut will undergo a series of tests before and after their flight, including measuring muscle stiffness and strength. Researchers will compare the results from astronauts using the EasyMotionSkin to those who did not use it, helping to identify the benefits of this innovative approach to exercise in space.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Astronauts with active Flight Medical
- Exclusion Criteria:
- • Heart disease
- • Liver disease
- • Diabetes
- • Thrombosis
- • Extreme blood pressure
- • Abdominal \& inguinal hernias (bulges)
- • Strong neurological diseases
- • Pregnancy
- • Cancer
About Charite University, Berlin, Germany
Charité - Universitätsmedizin Berlin is a leading academic medical center in Germany, renowned for its commitment to excellence in research, education, and patient care. As one of Europe's largest university hospitals, Charité integrates cutting-edge clinical practices with innovative research initiatives, fostering interdisciplinary collaboration across various medical fields. The institution is dedicated to advancing healthcare through rigorous clinical trials, contributing to the development of new therapies and treatment protocols. With a strong emphasis on translational medicine, Charité aims to bridge the gap between scientific discovery and practical application, ultimately enhancing patient outcomes and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Berlin Mitte, Berlin, Germany
Patients applied
Trial Officials
Dieter Blottner, PhD
Principal Investigator
Charite-Universitätsmedizin Berlin, Germany
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported